Cleopatra Hospitals Group S.A.E. (EGX: CLHO)

CLHO Statistics

Total Valuation

Cleopatra Hospitals Group S.A.E. has a market cap or net worth of EGP 12.72 billion. The enterprise value is 14.30 billion.

Market Cap	12.72B
Enterprise Value	14.30B

Important Dates

The next estimated earnings date is Wednesday, November 20, 2024.

Earnings Date	Nov 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Cleopatra Hospitals Group S.A.E. has 1.45 billion shares outstanding. The number of shares has decreased by -1.50% in one year.

Shares Outstanding	1.45B
Shares Change (YoY)	-1.50%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	1.77%
Float	535.90M

Valuation Ratios

The trailing PE ratio is 28.43 and the forward PE ratio is 18.94. Cleopatra Hospitals Group S.A.E.'s PEG ratio is 0.47.

PE Ratio	28.43
Forward PE	18.94
PS Ratio	2.90
PB Ratio	5.09
P/FCF Ratio	n/a
PEG Ratio	0.47

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.33, with an EV/FCF ratio of -18.36.

EV / Earnings	31.53
EV / Sales	3.26
EV / EBITDA	13.33
EV / EBIT	16.15
EV / FCF	-18.36

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.59.

Current Ratio	1.35
Quick Ratio	0.72
Debt / Equity	0.59
Debt / EBITDA	1.49
Debt / FCF	-2.06
Interest Coverage	10.21

Financial Efficiency

Return on equity (ROE) is 25.42% and return on invested capital (ROIC) is 15.39%.

Return on Equity (ROE)	25.42%
Return on Assets (ROA)	11.73%
Return on Capital (ROIC)	15.39%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.93
Inventory Turnover	10.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +132.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+132.19%
50-Day Moving Average	6.98
200-Day Moving Average	6.37
Relative Strength Index (RSI)	71.46
Average Volume (20 Days)	2,363,473

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cleopatra Hospitals Group S.A.E. had revenue of EGP 4.38 billion and earned 453.53 million in profits. Earnings per share was 0.31.

Revenue	4.38B
Gross Profit	1.55B
Operating Income	885.21M
Pretax Income	830.29M
Net Income	453.53M
EBITDA	1.05B
EBIT	885.21M
Earnings Per Share (EPS)	0.31

Balance Sheet

The company has 247.24 million in cash and 1.60 billion in debt, giving a net cash position of -1.35 billion or -0.94 per share.

Cash & Cash Equivalents	247.24M
Total Debt	1.60B
Net Cash	-1.35B
Net Cash Per Share	-0.94
Equity (Book Value)	2.72B
Book Value Per Share	1.73
Working Capital	611.94M

Cash Flow

In the last 12 months, operating cash flow was 688.46 million and capital expenditures -1.47 billion, giving a free cash flow of -779.06 million.

Operating Cash Flow	688.46M
Capital Expenditures	-1.47B
Free Cash Flow	-779.06M
FCF Per Share	-0.54

Margins

Gross margin is 35.38%, with operating and profit margins of 20.20% and 12.60%.

Gross Margin	35.38%
Operating Margin	20.20%
Pretax Margin	18.94%
Profit Margin	12.60%
EBITDA Margin	23.88%
EBIT Margin	20.20%
FCF Margin	-17.77%

Dividends & Yields

Cleopatra Hospitals Group S.A.E. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	21.04%
Buyback Yield	1.50%
Shareholder Yield	1.50%
Earnings Yield	3.52%
FCF Yield	-6.12%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cleopatra Hospitals Group S.A.E. has an Altman Z-Score of 3.34.

Altman Z-Score	3.34
Piotroski F-Score	n/a